MARK RICHMOND

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Armata Pharmaceuticals, Inc.

Filing Date Source Excerpt
2002-03-27 Mark Richmond (age 71) has served as a director of Targeted Genetics since July 1996. Dr. Richmond is a business consultant and a research fellow of the School of Public Policy, University College London.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22